Role of PRL2 in Rheumatoid Arthritis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100046850

Enrollment

Unknown

Registered

2021-05-29

Start date

2021-06-01

Completion date

Unknown

Last updated

2022-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Interventions

case series:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years; 2. Meeting the diagnostic criteria revised by the American College of Rheumatology (ACR) in 1987, which was diagnosed with rheumatoid arthritis.

Exclusion criteria

Exclusion criteria: Patients treated with biological agents.

Design outcomes

Primary

Measure	Time frame
Liver regenerative phosphatase 2;Oxidative stress;	—

Countries

China

Contacts

Public ContactWang Zhaojun

Shanghai Jiao Tong University School of Medicine

zjwang@sjtu.edu.cn+86 21 63846590

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026